⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3808233 | 0.77 | — | — | |
| SCHEMBL106433 | 0.77 | — | — | |
| SCHEMBL31444943 | 0.71 | — | — | |
| Methane SCHEMBL724933 | 0.71 | — | — | |
| Fluoride SCHEMBL5574172 | 0.71 | — | — | |
| SCHEMBL25332241 | 0.71 | — | — | |
| SCHEMBL4412627 | 0.71 | — | — | |
| SCHEMBL7738473 | 0.71 | — | — | |
| Iodide SCHEMBL3743824 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL25173719 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118281333-A | Electrolyte additive, nonaqueous electrolyte and application thereof | 深圳市研一新材料有限责任公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118281322-A | Electrolyte additive, nonaqueous electrolyte and application thereof | 深圳市研一新材料有限责任公司 | 2024-07-02 | — | — | CN | claimed |
| US-20240140933-A1 | OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER | HOFFMANN-LA ROCHE INC. (US) | 2024-05-02 | — | — | US | claimed |
| EP-4341252-A1 | OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER | F. Hoffmann-La Roche AG (CH) | 2024-03-27 | — | — | EP | claimed |
| CN-117321042-A | Oxodihydro indole compounds for the treatment of inflammatory diseases or cancers | 豪夫迈·罗氏有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-115960131-A | Preparation method of fluoro phosphate | 深圳市研一新材料有限责任公司 | 2023-04-14 | — | — | CN | claimed |
| EP-3438105-B1 | DIARYL- -LACTAM COMPOUND AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF | UNIV FUDAN (CN) | 2022-01-05 | — | — | EP | claimed |
| EP-3310795-B1 | POLYMERIZATION OF SILYL- AND FLUORO-CONTAINING MONOMERS | SCRIPPS RESEARCH INST (US) | 2021-06-16 | — | — | EP | claimed |
| US-20200392150-A1 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | FUDAN UNIVERSITY (CN) | 2020-12-17 | — | — | US | claimed |
| US-10717820-B2 | Polymerization of silyl- and fluoro-containing monomers | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-07-21 | — | — | US | claimed |
| EP-0515232-A1 | 2-benzocoumarinyl-carbapenems | MERCK & CO. INC. (US) | 1992-11-25 | — | — | EP | claimed |
| EP-0509756-A1 | 2-Phenanthridonyl carbapenems having cationizeable substituents | MERCK & CO. INC. (US) | 1992-10-21 | — | — | EP | claimed |
| US-5151512-A | Bactericides | MERCK & CO., INC. (US) | 1992-09-29 | — | — | US | claimed |
| US-5132421-A | 2-naphthyl-carbapenem intermediates | MERCK & CO., INC. (US) | 1992-07-21 | — | — | US | claimed |
| EP-0480712-A1 | 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0472306-A1 | 2-(9-fluorenonyl)-carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-02-26 | — | — | EP | claimed |
| EP-0467434-A1 | 2-Biphenyl-carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-01-22 | — | — | EP | claimed |
| EP-0466254-A1 | 2-naphthyl-carbapenems | MERCK & CO. INC. (US) | 1992-01-15 | — | — | EP | claimed |
| EP-0463852-A2 | 2-Phenanthrenyl-carbapenem antibacterial agents | MERCK & CO. INC. (US) | 1992-01-02 | — | — | EP | claimed |
| EP-0431794-A2 | 3-Fluorosulfonyloxyceph-3-EM displacement process | Bristol-Myers Squibb Company (US) | 1991-06-12 | — | — | EP | claimed |